Payment overview · 2025
General Payments
$121.81
1 reported records · 1 companies
Healthcare provider profile · identity verified
Timothy Beirne, MD
Allopathic & Osteopathic Physicians|Family Medicine · ROCKY MOUNT, VA · NPI 1255304168
Verified facts
What the public records show
CMS Open Payments records show Timothy Beirne, MD received $121.81 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $121.81 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $121.81 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $121.81 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 712 | 224 |
| Lisinopril | Lisinopril | 622 | 210 |
| Amlodipine Besylate | Amlodipine Besylate | 607 | 192 |
| Levothyroxine Sodium | Levothyroxine Sodium | 411 | 133 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 395 | 143 |
| Omeprazole | Omeprazole | 369 | 133 |
| Metoprolol Tartrate | Metoprolol Tartrate | 310 | 95 |
| Metformin Hcl | Metformin Hcl | 295 | 101 |
| Losartan Potassium | Losartan Potassium | 286 | 98 |
| Simvastatin | Simvastatin | 282 | 94 |
| Gabapentin | Gabapentin | 272 | 110 |
| Hydrochlorothiazide | Hydrochlorothiazide | 249 | 103 |
| Pantoprazole Sodium | Pantoprazole Sodium | 244 | 88 |
| Sertraline Hcl | Sertraline Hcl | 227 | 71 |
| Glimepiride | Glimepiride | 209 | 67 |
| Furosemide | Furosemide | 207 | 77 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 206 | 79 |
| Metoprolol Succinate | Metoprolol Succinate | 193 | 67 |
| Meloxicam | Meloxicam | 188 | 74 |
| Tamsulosin Hcl | Tamsulosin Hcl | 182 | 64 |
| Tramadol Hcl | Tramadol Hcl | 175 | 45 |
| Eliquis | Apixaban | 174 | 58 |
| Metformin Hcl Er | Metformin Hcl | 171 | 54 |
| Diclofenac Sodium | Diclofenac Sodium | 152 | 74 |
| Allopurinol | Allopurinol | 151 | 49 |
| Carvedilol | Carvedilol | 142 | 50 |
| Fluticasone Propionate | Fluticasone Propionate | 140 | 42 |
| Trazodone Hcl | Trazodone Hcl | 139 | 56 |
| Clopidogrel | Clopidogrel Bisulfate | 130 | 41 |
| Montelukast Sodium | Montelukast Sodium | 123 | 36 |
| Alprazolam | Alprazolam | 119 | 40 |
| Potassium Chloride | Potassium Chloride | 112 | 33 |
| Ozempic | Semaglutide | 111 | 26 |
| Tizanidine Hcl | Tizanidine Hcl | 110 | 38 |
| Pravastatin Sodium | Pravastatin Sodium | 108 | 33 |
| Buspirone Hcl | Buspirone Hcl | 106 | 33 |
| Jardiance | Empagliflozin | 103 | 27 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 98 | 30 |
| Citalopram Hbr | Citalopram Hydrobromide | 96 | 39 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 94 | 64 |
| Spironolactone | Spironolactone | 91 | 29 |
| Duloxetine Hcl | Duloxetine Hcl | 83 | 30 |
| Escitalopram Oxalate | Escitalopram Oxalate | 81 | 29 |
| Terazosin Hcl | Terazosin Hcl | 77 | 24 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 76 | 23 |
| Valsartan | Valsartan | 76 | 22 |
| Mirtazapine | Mirtazapine | 73 | 23 |
| Pregabalin | Pregabalin | 72 | 25 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 69 | 23 |
| Clonazepam | Clonazepam | 68 | 17 |
| Lovastatin | Lovastatin | 68 | 22 |
| Alendronate Sodium | Alendronate Sodium | 67 | 26 |
| Lorazepam | Lorazepam | 66 | 28 |
| Bupropion Xl | Bupropion Hcl | 65 | 20 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 65 | 26 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 65 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 65 | 22 |
| Atenolol | Atenolol | 64 | 25 |
| Labetalol Hcl | Labetalol Hcl | 64 | 17 |
| Famotidine | Famotidine | 63 | 23 |
| Prednisone | Prednisone | 63 | 48 |
| Baclofen | Baclofen | 61 | 24 |
| Dicyclomine Hcl | Dicyclomine Hcl | 56 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 56 | 26 |
| Promethazine Hcl | Promethazine Hcl | 56 | suppressed |
| Amoxicillin | Amoxicillin | 55 | 44 |
| Doxazosin Mesylate | Doxazosin Mesylate | 55 | 18 |
| Meclizine Hcl | Meclizine Hcl | 54 | 26 |
| Trulicity | Dulaglutide | 53 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 53 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 52 | 16 |
| Cephalexin | Cephalexin | 50 | 30 |
| Klor-Con M20 | Potassium Chloride | 50 | 19 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 48 | 20 |
| Naproxen | Naproxen | 48 | 27 |
| Ramipril | Ramipril | 47 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 46 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 46 | 14 |
| Mounjaro | Tirzepatide | 46 | 12 |
| Synthroid | Levothyroxine Sodium | 46 | 14 |
| Azithromycin | Azithromycin | 45 | 36 |
| Estradiol | Estradiol | 44 | 15 |
| Diazepam | Diazepam | 42 | 13 |
| Ezetimibe | Ezetimibe | 42 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 42 | 16 |
| Benazepril Hcl | Benazepril Hcl | 41 | suppressed |
| Cefdinir | Cefdinir | 41 | 33 |
| Cefadroxil | Cefadroxil | 39 | 34 |
| Nortriptyline Hcl | Nortriptyline Hcl | 39 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 39 | 15 |
| Irbesartan | Irbesartan | 38 | 12 |
| Temazepam | Temazepam | 37 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 36 | 11 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 36 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 36 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 35 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 35 | 13 |
| Azelastine Hcl | Azelastine Hcl | 34 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 34 | 33 |
| Methocarbamol | Methocarbamol | 34 | 14 |
| Celecoxib | Celecoxib | 33 | 12 |
| Chlorthalidone | Chlorthalidone | 33 | 12 |
| Colchicine | Colchicine | 33 | 18 |
| Ibuprofen | Ibuprofen | 33 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | 22 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 32 | 11 |
| Nystatin | Nystatin | 32 | 15 |
| Glipizide | Glipizide | 31 | 13 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 31 | 11 |
| Ondansetron Odt | Ondansetron | 31 | 11 |
| Doxepin Hcl | Doxepin Hcl | 30 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 30 | 23 |
| Enalapril Maleate | Enalapril Maleate | 30 | suppressed |
| Finasteride | Finasteride | 30 | 12 |
| Sucralfate | Sucralfate | 30 | 14 |
| Felodipine Er | Felodipine | 28 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 28 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 28 | 12 |
| Dutasteride | Dutasteride | 27 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 27 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 27 | 14 |
| Nitroglycerin | Nitroglycerin | 26 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 26 | suppressed |
| Topiramate | Topiramate | 26 | suppressed |
| Mupirocin | Mupirocin | 25 | 16 |
| Lansoprazole | Lansoprazole | 24 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 24 | suppressed |
| Levemir Flexpen | Insulin Detemir | 23 | suppressed |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 23 | 17 |
| Tresiba Flextouch U-200 | Insulin Degludec | 23 | suppressed |
| Glipizide Er | Glipizide | 21 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 21 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 20 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 20 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 19 | suppressed |
| Bumetanide | Bumetanide | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 19 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 19 | suppressed |
| Gemfibrozil | Gemfibrozil | 18 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 18 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 18 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 18 | 13 |
| Paxlovid | Nirmatrelvir/Ritonavir | 17 | 17 |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Memantine Hcl | Memantine Hcl | 16 | suppressed |
| Metronidazole | Metronidazole | 16 | suppressed |
| Torsemide | Torsemide | 16 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 15 | suppressed |
| Risperidone | Risperidone | 15 | suppressed |
| Telmisartan | Telmisartan | 15 | suppressed |
| Travoprost | Travoprost | 15 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Januvia | Sitagliptin Phosphate | 14 | suppressed |
| Nifedipine Er | Nifedipine | 14 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 14 | 13 |
| Olanzapine | Olanzapine | 14 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 14 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 14 | suppressed |
| Xarelto | Rivaroxaban | 14 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | suppressed |
| Methylprednisolone | Methylprednisolone | 12 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Nabumetone | Nabumetone | 11 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $121.81 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error